2010

Likvor receives an order for a Likvor CELDA[sup]®[/sup] System from Örebro University Hospital, Sweden

With Likvor CELDA® System the Örebro University Hospital will be able to measure the dynamics of the most important parameters concerning the patients' cerebrospinal fluid including pressure and flow in a controlled and safe process. Likvor CELDA® System was developed to facilitate greater understanding and enhance diagnosis of normal pressure hydrocephalus (NPH) a condition that is often mistaken for dementia.

Likvor AB presents at BioJapan 2010

Likvor AB will appear at BioJapan. Likvor AB will be presenting CELDA® Instrument and answering any questions regarding the product. Likvor AB is currently focusing on expanding the international and global sales network with potential business partners and distributors for CELDA® Instrument.

Likvor presents at Tübingen Germany

Likvor will appear at the 14th international conference on Intercranial Pressure and Brain Monitoring. Likvor will be demonstrating CELDA® Instrument and answering any questions regarding the product. Likvor is at present focusing on expanding the international and global sales network with potential business partners for CELDA® Instrument.

Likvor presents at international NPH workshop in Greece

For the first time since Likvor recieved the CE certification in September 2009, the CELDA® Instrument will be demonstrated at the International workshop on NPH Crete-Greece. In addition to demonstrating CELDA®, Likvor is looking for collaborators that will assist in the introduction of CELDA® Instrument to the international market.

Likvor's first international order

LinkMed's portfolio company Likvor has received its first order for the Likvor CELDA® system from a customer outside Sweden. The order comes from Aalborg Hospital which is the largest hospital in the North Denmark Region. This is the fifth order for the instrument since it got CE marked in September, 2009. With Likvor CELDA® the clinic will be able to measure the dynamics of the most important parameters concerning the patients' cerebrospinal fluid including pressure and flow in a controlled and safe process. Likvor CELDA® was developed to facilitate greater understanding and enhance diagnosis of normal pressure hydrocephalus (NPH), a condition that is often mistaken for dementia.

Likvor receives an order for CELDA[sup]®[/sup] from Sahlgrenska University Hospital in Gothenburg

LinkMed's portfolio company Likvor has received an order for Likvor CELDA® from Sahlgrenska University Hospital in Gothenburg. With Likvor CELDA® the clinic will be able to dynamic measure the most important parameters concerning the patients' cerebrospinal fluid including pressure and flow in a controlled and safe process. Likvor CELDA® was developed to facilitate greater understanding and enhance diagnosis of normal pressure hydrocephalus (NPH), a condition that is often mistaken for dementia. This is the third order for the instrument since it got CE marked.

Likvor receives an order for CELDA[sup]®[/sup] from the University Hospital in Linköping

LinkMed's portfolio company Likvor has received an order for Likvor CELDA® from the University Hospital in Linköping. With Likvor CELDA® the clinic will be able to dynamic measure the most important parameters concerning the patients' cerebrospinal fluid including pressure and flow in a controlled and safe process. Likvor CELDA® was developed to facilitate greater understanding and enhance diagnosis of normal pressure hydrocephalus (NPH), a condition that is often mistaken for dementia. This is the fourth order for the instrument since it got CE marked.